Your browser doesn't support javascript.
loading
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p.
Blood ; 119(4): 940-8, 2012 Jan 26.
Article in En | MEDLINE | ID: mdl-22160383

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Stem Cell Transplantation / Induction Chemotherapy / Maintenance Chemotherapy / Multiple Myeloma / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2012 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazines / Boronic Acids / Stem Cell Transplantation / Induction Chemotherapy / Maintenance Chemotherapy / Multiple Myeloma / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2012 Type: Article Affiliation country: Germany